(Q30357518)

English

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 June 2017

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. (English)

1 reference

Europe PubMed Central

20 June 2017

0 references

pandemic potential

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

6

object named as

Cox NJ

1 reference

Europe PubMed Central

20 June 2017

author name string

Desheva JA

1

1 reference

Europe PubMed Central

20 June 2017

Lu XH

2

1 reference

Europe PubMed Central

20 June 2017

Rekstin AR

3

1 reference

Europe PubMed Central

20 June 2017

Rudenko LG

4

1 reference

Europe PubMed Central

20 June 2017

Swayne DE

5

1 reference

Europe PubMed Central

20 June 2017

Katz JM

7

1 reference

Europe PubMed Central

20 June 2017

Klimov AI

8

1 reference

Europe PubMed Central

20 June 2017

language of work or name

0 references

publication date

28 June 2006

1 reference

Europe PubMed Central

20 June 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

20 June 2017

24

1 reference

Europe PubMed Central

20 June 2017

47-48

1 reference

Europe PubMed Central

20 June 2017

6859-6866

1 reference

Europe PubMed Central

20 June 2017

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

The evolution of H5N1 influenza viruses in ducks in southern China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Evolution of H5N1 avian influenza viruses in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Comparative pathobiology of low and high pathogenicity H7N3 Chilean avian influenza viruses in chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Pathogenicity and antigenicity of a new influenza A (H5N1) virus isolated from duck meat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Protection of mice with recombinant influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

A novel mechanism for the acquisition of virulence by a human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Interrupting the transmission of respiratory tract infections: theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

based on heuristic

inferred from DOI database lookup

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.06.023

1 reference

Europe PubMed Central

20 June 2017

1 reference

Europe PubMed Central

20 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30357518&oldid=1974386712"